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A Naturalistic Study of Medication Reduction 
in a Residential Treatment Setting
Daniel F. Connor, M.D., and Thomas J. McLaughlin, Sc.D.
ABSTRACT
The primary aim of this pilot study was to ascertain if psychiatric medications could be re-
duced in a convenience sample of seriously emotionally disturbed children and adolescents
over the course of residential treatment. We also sought to understand factors correlated with
reduction in the number of medications during treatment. A review of the treatment of 141
patients (n = 112 admitted on medication and n = 29 admitted on no medication) admitted to,
and discharged from, a residential treatment setting between 1992 and 2001 was undertaken.
Significantly more children were discharged from treatment on no medications than were ad-
mitted to residential treatment on no medications. In children receiving more than 1 medica-
tion at admission, the number of combined medications was significantly reduced over the
course of residential treatment. However, the majority of children admitted on medications
continued on some psychiatric medications, indicating that psychopharmacology continued
to play an important role in their treatment. In 112 patients admitted on psychoactive medica-
tions, our pilot data suggests that improvement in externalizing, internalizing, psychotic, and
autistic psychopathology while in residential treatment, the presence of an intact family
(adoptive or biological), the absence of a history of either sexual or physical abuse, and the
type of medication used appear to be factors that correlate with a reduced use of medications
in this population.
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INTRODUCTION
CHILDREN AND ADOLESCENTS with serious emo-tional disturbances (SED) often present to
clinicians with severe impairments and chronic,
intense, and treatment-resistant symptoms. Some
of these children and adolescents (referred to
hereafter as children) may have been exposed to
multiple psychiatric medications, beginning at
an early age and continuing for extended periods
of time. More frequent medication interven-
tions, with an increasing number of concurrent
psychiatric medications and with prescription
at ever-younger ages, have been documented by
several investigators in various study samples
(Connor et al. 1998; Zito et al. 2000; Zito et al.
2003). Rates of pediatric antidepressant, anti-
psychotic, and stimulant use, and coprescription
of multiple concurrent classes of psychiatric
medications for youths less than 18 years of age
expanded markedly between 1987 and 2002 in
the United States (Olfson et al. 2002; Patel et al.
2002; Zito et al. 2003). Clinical use of other psy-
chotropic medications in the pediatric age range,
such as clonidine for ADHD, atypical antipsy-
chotics, anticonvulsants for psychiatric disor-
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ders, benzodiazepines, and lithium is also in-
creasing (Jensen et al. 1999; Zito et al. 2003).
Youths with SED admitted to institutional
services appear to have especially high rates of
pediatric psychopharmacology use and multi-
ple concurrent medication use. One study of the
patterns of psychotropic and anticonvulsant
medication use in 83 SED children in residen-
tial treatment found that, at admission, 76% of
children were receiving at least 1 psychotropic
medication and 40% of children were admitted
receiving more than 1 psychoactive medication
concurrently (Connor et al. 1998). When lifetime
treatment history was assessed in this study,
57% of children had received trials of multiple
concurrent psychotropic medications before ad-
mission. Of multiple medication treatments, 52%
involved 2 psychotropic medications, 29% in-
volved 3 drugs, 11% involved 4 drugs, and 7.9%
involved 5 different medications given simul-
taneously in combination. Thus, almost half of
the medication interventions given to these chil-
dren involved 3 or more drugs, and remarkably,
19% entailed 4 or more drugs given simultane-
ously. There were 89 identifiable, distinct, mul-
tiple medication trials in these 83 children,
encompassing 52 different combinations of med-
ications (Connor et al. 1998). To date, few con-
trolled studies are available that assess the
efficacy and safety of 2 medications combined
in referred children (Safer et al. 2003). There are
presently no controlled studies examining the
efficacy and tolerability of multiple combina-
tions of greater than 2 concurrently prescribed
psychotropic medications for children with or
without SED symptoms (Jensen et al. 1999; Safer
et al. 2003).
Given concerns about the use of multiple
medication combinations in psychiatrically re-
ferred youngsters, studies investigating whether
or not psychiatric medications can be safely
discontinued, and variables associated with suc-
cessful medication discontinuation, are impor-
tant for clinicians. When faced with the child
presenting on multiple concurrent medications,
it is important for the clinician to know which
child, family, and medication variables might
be associated with successful medication reduc-
tion, especially in inpatient and residential treat-
ment settings. Presently, we are aware of no
studies assessing whether multiple combina-
tions of psychotropic medications, having been
prescribed for children, can be safely and effec-
tively tapered so that a smaller number of med-
ications remains in use. This data vacuum exists
for both SED and non-SED children, and for chil-
dren both within and outside of institutional-
care settings.
We carried out a naturalistic pilot study, ret-
rospectively reviewing psychotropic medication
use among children, 6 to 19 years of age, with
various emotional and behavioral problems,
who were admitted to a well-established resi-
dential treatment center over a 9-year period,
from 1992 through 2001. The primary aims of
this study were to ascertain if medications could
be safely reduced in children prescribed med-
ications at admission to residential treatment
and to identify patient characteristics, medica-
tion types, and clinical circumstances that were
associated with the presence or absence of re-
duced psychotropic medication use by the time
of discharge from the institution.
SUBJECTS AND METHODS
Throughout the residential stay, child psychi-
atrists, who were responsible for medication
management, implemented best-practice efforts
to prescribe medications (AACAP 1997; Steiner
1997), and carefully followed children every 4–
6 weeks to assess safety, tolerability, and med-
ication efficacy. Medication changes were made
as a routine component of clinical care, with
these agent or dose changes recorded in the
medical record. No a priori decisions were made
at the start of this study to reduce medication
levels for any child in residential treatment. A
total of 8 separate child psychiatrists were
involved in this effort over the 9 years that com-
prise retrospective review. All treating psychi-
atrists were unaware of the aims of this study.
As a routine part of institutional care, clinical
assessment data were available in the medical
record—as recorded at admission—periodically
through each patient’s stay, and at discharge.
History data included complete psychiatric and
medical history information, including relevant
family history data. In particular, physical or sex-
ual abuse history, parental violence, and parental
substance abuse data were obtained for each
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child. In addition to these routinely recorded
medical records data, at admission and at dis-
charge, a reliable and valid measure of psy-
chopathology the Devereux Scales of Mental
Disorder (DSMD; Naglieri et al. 1994), were
administered to all children.
Consent
All data used in this study were obtained as
part of the standard clinical care provided to
all clients of this residential center. As is stan-
dard practice, any medication changes in the
institution were reviewed with the child’s guar-
dian, and guardian and patients’ assent to these
changes was obtained. Data in this review were
collected in such a way as to protect the confi-
dentiality of the clients, and data sets were
purged of data that could be used to identify
patients. The retrospective review of data was
reviewed and approved by the University of
Massachusetts Medical School Institutional Re-
view Board and the Client Care Monitoring
Board of the residential treatment center. After
a full explanation of the review procedure, in-
dependent written, informed consent was ob-
tained from all parents and guardians.
Treatment setting
The clinical setting is a not-for-profit residen-
tial treatment program serving seriously emo-
tionally disturbed children and adolescents from
the New England and Mid-Atlantic regions of
the United States. Children and adolescents are
placed in this facility through referrals from child
protective service agencies; departments of men-
tal health and education of nearby states; as part
of a continuum of care after acute inpatient psy-
chiatric hospitalization; through placement by
juvenile justice authorities as an alternative to
incarceration; and by referral from local school
districts, when the school is unable to educate
and maintain the student within the school
community.
The RTC setting provides a highly struc-
tured milieu, organized around group therapy
programs managed by well-trained staff that
emphasize safety skills, assertiveness and com-
munication training, social problem-solving
skills, and academic remediation. There also are
strong community service and family outreach
components, and the school maintains close
contact with hospitals and other providers in
the area. Treatment is conceptualized along a
continuum of care with every discharged child
receiving psychoeducational after-care services.
There is a 3:1 client-to-staff ratio. Treatment
components include individual psychotherapy,
group therapy, behavioral therapy, milieu ther-
apy, and individualized pharmacotherapy, with
medication treatment managed by consulting
child and adolescent psychiatrists. All children
receive special education services in a highly
structured school environment featuring a small
class size, with 8 students, 1 teacher, and 1 aide
per class on average. Length of stay ranges
from several months to several years.
Subjects
We reviewed the records of all children (n =
171) admitted to this residential center between
1992 and discharged during or before 2001.
Complete medication records were available on
141 subjects (112 subjects receiving medications
at the time of admission and 29 subjects admit-
ted free of medications). The 30 subjects with
missing medication data were compared to sub-
jects with complete data sets to examine for any
systematic differences that might arise from
missing data. No significant differences were
found when the complete group was compared
to the missing group on gender, verbal IQ, a
developmental history of physical and/or sex-
ual abuse, developmental history of parental
violence, and length of stay in placement (p =
NS). A significant difference was found in age
at admission (t = 2.89; p = 0.004). The group ad-
mitted on medication was significantly younger
at the time of admission (13.1 ± 2.6 years) than
the group with missing medication data (14.6 ±
2.8 years). Of these 141 children with complete
medication data sets, 112 children were ad-
mitted on medications and form the subset for
this analysis.
Diagnostic procedures
All admitted children received a psychiatric
evaluation and all met criteria for at least one
psychiatric diagnosis. However, the frequent
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presence of cognitive delay and expressive and
receptive language delays in children resulted
in a lack of confidence in the reliability of these
psychiatric diagnoses obtained by clinical in-
terview. Accordingly, psychiatric diagnosis was
not used as an explanatory or stratification mea-
sure in this study.
The standard evaluation in this institution
included the following measures.
Measures
Psychopathology. The Devereux Scales of Mental
Disorder (DSMD) is a 110-item behavior rating
scale designed to evaluate psychopathology in
children and adolescents (Naglieri et al. 1994).
The DSMD assesses psychopathology along con-
tinuous dimensions, so that categorical psychi-
atric diagnoses are not derived from the DSMD.
There are three composite scores obtained from
the DSMD scale: Internalizing, externalizing, and
critical pathology, and a total score. Behaviors
that involve aggression, violence, hyperactivity,
impulsivity, oppositional behaviors, and conflicts
between the child and his or her environment are
measured by the externalizing composite; behav-
iors that reflect the child’s state of psychological
well-being, such as anxiety and depression, are
assessed by the internalizing composite, and se-
vere disturbances, such as autism or psychosis,
are measured by the critical psychopathology
composite. The total scale score provides an as-
sessment of overall psychopathology. DSMD
standardization data, based on a large sample
representative of the U.S. population comprising
3153 children and adolescents 5 to 18 years of
age, indicate that the DSMD instrument has high
internal consistency, as well as excellent test-
retest reliability. Inter-rater reliability, when ex-
amined across parent and teacher raters, was
adequate (range, 0.44–0.66; all p < 0.01) (Naglieri
et al. 1994). Item content and content-related va-
lidity adequately reflect Diagnostic and Statistical
Manual of Mental Disorders, 4th edition (DSM-IV)
criteria (Naglieri et al. 1994). The DSMD is treat-
ment-sensitive and reliably assesses psychopa-
thology over the previous 4 weeks (Naglieri et al.
1994). As noted above, the DSMD was completed
by staff at admission (baseline) and again at dis-
charge from treatment. Change-from-baseline
measures for all DSMD scales were ascertained.
Historical and demographic variables. Chart re-
view variables included age at admission to
the current residential placement, gender, cur-
rent primary caregiver, number of out-of-home
placements (the current placement was not
counted), family history of parental violence
and/or substance abuse, and child history of
physical and/or sexual abuse. Physical or sex-
ual abuse history was only coded as present if
the clinical record supported a documented
change of caregiver because of suspected abuse,
court appearance because of abuse charges, or
a supported protective services evaluation of
abuse as mandated by state law. Type of med-
ications assessed at admission, and then again
at discharge, included neuroleptics and anti-
psychotics, stimulants, antidepressants, lithium,
anticonvulsants used for psychiatric disorders
(valproex sodium and carbamazepine), and
clonidine.
Reliability
Inter-rater reliability studies on chart review
and treatment variables were completed on a
random sample of 34 of 112 subjects (30%) on
medications at admission, with data provided
by two child psychiatrist raters. Results (k,
kappa; ICC, intraclass correlation) were as
follows: Parental history of alcohol/substance
(K = 1.0), parental history of violence (K = 1.0),
history of physical abuse (K = 0.85), history of
sexual abuse (K = 0.93), and number of med-
ications at admission (ICC = 0.97). The median
kappa for chart review and treatment items was
0.94. No formal inter-rater reliability data on the
DSMD were obtained because of the documen-
tation of adequate reliability of the instrument
provided by the authors (Naglieri et al. 1994).
Statistical analysis
We categorized each subject having at least
one psychotropic medication at admission (n =
112) as either medication-reduced or medica-
tion not reduced at discharge. The medication-
reduced category included all children whose
medication regimen included fewer distinct
psychiatric medications at discharge than at ad-
mission. The not-medication-reduced category
included all other children with at least one med-
NATURALISTIC STUDY OF MEDICATION 305
13961C19.pgs  5/3/05  11:52 AM  Page 305
ication at admission. The medication-reduced
and medication-not-reduced subgroups were
compared on study variables assessing demo-
graphics, psychiatric history, psychopathology,
and family circumstances. We compared the two
groups on the number and type of psychotro-
pic medications at admission and at discharge.
Univariate statistical analysis of categorical and
continuous data was accomplished by the use
of chi-square and paired t tests, respectively.
Some variables (e.g., length-of-stay) were log-
transformed prior to modeling to achieve more
normal distributions. Univariate data are re-
ported as mean (±SD) or n (%). For each sub-
ject, we obtained DSMD change-from-baseline
(discharge minus admission) psychopathology
data on the DSMD total score and the three
DSMD composite scores. Analyses of covari-
ance models were used to adjust for baseline
differences in the three DSMD composite scales
and the total score. Statistical significance was
set at p  0.05.
RESULTS
Patient characteristics
Characteristics of the 141 subjects with com-
plete medication data are presented in Table 1.
Comparisons are made between the 112 chil-
dren admitted on medications and the group
of 29 children admitted without medications.
Children admitted without medications were
significantly older than children admitted on
medications (13.3 ± 2.5 years versus 14.2 ± 1.8
years) (t = 2.23; p = 0.03). Children admitted
without medications had fewer “other family
configurations” than children admitted on
medications (6.9% other family configurations
versus 36.6%) (2 = 9.6; p = 0.002). Children
with higher DSMD scores at admission also re-
ceived more medications at admission (inter-
nalizing score, t = 2.42; p = 0.02; total score, t =
2.01, p = 0.05). Other demographic, family,
psychiatric history, and length of stay in resi-
dential treatment did not distinguish the two
groups.
The majority of subjects in the two groups
were male, with over half coming from biolog-
ical parent or adoptive parent homes. Mean
verbal IQ was a standard deviation below the
expected population mean for nonreferred
youngsters. Over half the subjects had experi-
enced either physical or sexual abuse in their
developing years, and the majority of patients
in the two groups came from families charac-
terized by substance abuse in parents and/or
parental violence. Almost all children had ex-
perienced a previous placement prior to en-
rollment in the residential treatment program.
All subjects were classified as seriously emo-
tionally disturbed (SED) for educational pur-
poses. Of the group receiving medications (n =
112), 64 patients (57.2%) were receiving more
than 1 psychotropic medication, with an aver-
age of 2.64 ± 1.3 (range, 1–6) concurrent med-
ications at admission.
Correlates of medication reduction
Among the 112 children admitted receiving
medication, 74 children (66.1%) were discharged
from residential treatment on less medication
than at admission, and 38 children (33.9%) did
not have medications reduced at discharge com-
pared with the number at admission. Several
factors significantly discriminated the reduced
and nonreduced subjects. Children admitted on
medications with a biological or adoptive par-
ent caregiver were more likely to be discharged
on fewer medications than at admission (71.4%
versus 18.4%) (2 = 8.6; p = 0.003). Children
admitted on greater numbers of concurrent
medications were more likely to have reduced
medications at discharge (3.09 ± 1.3 versus
1.79 ± 0.8 medications) (t = 4.84; p < 0.001).
There existed a strong trend in the data for
abused children to be less likely to have med-
ication reductions at discharge than nonabused
children, but this did not quite reach statistical
significance (76.3% versus 57.1%) (2 = 3.62;
p = 0.057).
Drug type and medication reduction
Changes in use of specific drug types over
the course of residential treatment for the 112
children admitted on medications are described
in Table 2. As can be seen, neuroleptic and
antipsychotic, antidepressant, anticonvulsant,
lithium, and clonidine use significantly dimin-
ished, comparing use at discharge with use at
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TABLE 1. CHARACTERISTICS OF 141 RESIDENTIAL PATIENTS ON/NOT ON MEDICATIONS AT THE TIME OF ADMISSION
N (%) or mean (SD) (range)
Characteristic* On medication (n = 112) Not on medication (n = 29) p value†
Demographics
Sex
(n, % males) 89 (79.5) 25 (86.2) NS
(n, % females) 23 (20.5) 4 (13.8) NS
Age, at admission 13.3 ± 2.5 (6–19) 14.2 ± 1.8 (10–19) 0.03
IQ, verbal 84.1 ± 16.7 (46–128) 85.1 ± 18.5 (55–124) NS
Psychiatric History
Physical/Sexual Abuse 72 (64.2) 16 (56.1) NS
Children with  1 placement** 107 (95.5) 28 (96.5) NS
Family History
Parents (n, %)
Biological 58 (51.8) 17 (58.6) NS
Adoptive 13 (11.6) 13 (6.9) NS
Other 41 (36.6) 2 (6.9) 0.002
Parental violence history 81 (72.3) 21 (72.4) NS
Parental substance abuse history 77 (68.7) 18 (62.1) NS
DSMD Psychopathology T-Scores
at Admission‡
Externalizing T-Score 56.5 ± 10.4 52.5 ± 9.3 NS
Internalizing T-Score 62.4 ± 12.8 56.0 ± 10.6 0.02
Critical Pathology T-Score 57.3 ± 11.6 54.4 ± 11.9 NS
Total T-Score 59.5 ± 11.8 54.5 ± 10.6 0.05
Medications at Admission
On 1 psychiatric medication 48 (19.7) 0
On 2 psychiatric medications 0 (0.0) 0
On 3 psychiatric medications 24 (21.4) 0
On 4 psychiatric medications 31 (27.7) 0
On 5 psychiatric medications 7 (6.3) 0
On 6 psychiatric medications 2 (1.8) 0
Total number of medications 2.64 ± 1.3 (1–6) 0
Treatment Variables
Length-of-stay (days) 662.5 ± 426.6 (39–1847) 506 ± 346.5 (138–1676) NS
*For binary measures, n (%) is reported; for continuous measures, mean ± standard deviation (range).
**Not counting admission to current placement.
†t test for continuous variables; 2 test for dichotomous variables.
‡df = 7, 135.
DSMD, Devereaux Scales of Mental Disorder; NS, not specified.
TABLE 2. CHANGES IN MEDICATION USAGE OVER THE COURSE OF RESIDENTIAL TREATMENT, BY DRUG TYPE (N = 112)
Drug type Admission n (%) Discharge n (%) 2* p value
Neuroleptics/antipsychotics 53 (47.3) 15 (14.0) 27.4 <0.0002
Stimulants 32 (28.6) 35 (31.3) 0.1 0.77
Antidepressants 69 (61.6) 46 (41.1) 8.1 0.001
Anticonvulsants 45 (40.2) 25 (22.3) 6.0 0.004
Lithium 9 (8.0) 3 (2.7) 2.2 0.05
Clonidine 38 (39.3) 16 (14.3) 6.8 0.003
*Fischer’s exact test.
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admission. In contrast, stimulant medication
use did not decrease over the course of treat-
ment. Examining the entire sample of 141 chil-
dren for whom complete medication data was
available, the number of children discharged
from residential treatment on no medication
(n = 40) significantly differed from the number
(n = 29) admitted on no medication (2 = 27.6;
p = 0.0001). Of the 112 children on admission
medications, 19 children were discharged off
all medications. Of the 29 children admitted
on no medications, 21 children were discharged
on no medications. The number of children on
multiple concurrent medications dropped sub-
stantially, from 78% (87 of 112) of subjects at
admission to 48% (48 of 101) at discharge. This
suggests that, even among SED children admit-
ted on multiple combined psychopharmacologi-
cal regimens, psychiatric medications can be
reduced in highly structured treatment settings.
However, the majority were discharged on some
medication, indicating that psychopharmacol-
ogy continued to be an important component
of treatment for these seriously emotionally
disturbed children, despite the substantial re-
duction in the total number of medications taken
over the course of residential treatment.
DSMD psychopathology scores and
medication reduction
Comparisons between medication reduced/
not reduced groups (n = 112) on change-from-
baseline DSMD psychopathology composite and
total scores were completed using analysis of
covariance (ANCOVA) controlling for variabil-
ity in baseline DSMD scores. Findings indicated
a significant difference for all DSMD T-Score
comparisons: Externalizing score, t[2,109] = 2.23,
p = 0.02; internalizing score, t[2,109] = 2.05, p = 0.04;
critical pathology, t[2,109] = 2.10, p = 0.04; and
total score, t[2,109] = 2.40, p = 0.02; indicating
that medication reduction is correlated with di-
minishing psychopathology scores in the sample.
DISCUSSION
We completed a single-site pilot study inves-
tigating change in psychiatric medication use
over the course of treatment in a convenience
sample of children with severe emotional and
behavioral disorders admitted to, and discharged
from, residential treatment. We were particu-
larly interested in whether psychiatric medica-
tion use could be reduced in children with
psychiatric problems severe and chronic enough
to require residential treatment and variables
correlated with change in medication status over
the course of treatment.
Neuroleptic or antipsychotic, antidepressant,
anticonvulsant use for psychiatric disorders,
lithium, and clonidine use were all significantly
reduced at discharge, compared to admission.
Stimulant use did not decrease over the course
of treatment, probably reflecting high rates of
attentional deficits and hyperactive and impul-
sive behavior in this population (Connor et al.
1998). Significantly more children were dis-
charged from treatment on no medication (n =
40) than were admitted to residential treatment
on no medication (n = 29). Considering com-
bined pharmacotherapy, on average the num-
ber of medications at discharge was only 65%
of the number of admission medications, among
subjects with at least 1 medication at admis-
sion. As well, the number of children on multi-
ple medications dropped substantially, from 78%
of subjects at admission to 48% at discharge.
Given concerns about high rates of combined
pharmacotherapy in seriously emotionally dis-
turbed children in residential treatment (Connor
et al. 1997), these results suggest that multiple
and complex medication regimens can be re-
duced in therapeutic and structured treatment
environments characterized by the use of physi-
cian best-practice prescribing guidelines and
relatively long lengths of stay. In residential and
long-term inpatient treatment settings, prescrib-
ing clinicians should actively and continuously
attempt to ascertain which children require con-
tinued multiple medication regimens and in
which patient medications can be safely re-
duced. However, it should be noted that the
majority of patients admitted to residential treat-
ment on medications continued to require them
at discharge, suggesting that psychiatric med-
ications continued to be an important compo-
nent of their overall treatment plan.
We identified several factors correlated with
reduced medication use. Children who: (1) re-
sponded to residential treatment with dimin-
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ishing psychopathology and lessening inter-
nalizing, externalizing, psychotic, and autistic
symptoms, (2) who were admitted to residen-
tial treatment from more intact families with
biological or adoptive parents, and (3) who were
receiving nonstimulant psychiatric medications
were significantly more likely to reduce their
psychiatric medications over the course of treat-
ment. A trend in the data suggested that chil-
dren with no history of physical or sexual abuse
were significantly more likely to reduce their
psychiatric medications over the course of treat-
ment than abused children. It is possible that
these characteristics describe a sample of chil-
dren with serious emotional and behavioral dis-
orders who may respond most strongly to the
multidisciplinary psychoeducational treatment
offered in residential centers, and require less
medication upon discharge from care than they
required at admission to treatment.
Furthermore, our results suggest the possi-
bility that interactions between the treatment
environment, individual child characteristics,
and drug type may be a fruitful area of further
research useful in increasing the understanding
of psychopharmacology use in SED children in
naturalistic treatment settings. Characteristics
of the treatment environment (length of stay,
degree of therapeutic behavioral structure) and/
or individual psychiatric history (abuse history,
intactness of family structure) may interact with
medication type (nonstimulants) to further ex-
plain variance in which children can and cannot
reduce medication use in inpatient treatment
settings.
There was a robust correlation between im-
provement in DSMD psychopathology scores
and medication reduction in our sample. This
association was found for both internalizing
and externalizing psychopathology. Because of
the naturalistic organization of this study, we
cannot determine if clinical improvement in
psychopathology among children resulted in
reductions in the number of medications they
were prescribed, or whether the reduction in
the number of medications resulted in reduced
symptom severity. Perhaps both interpretations
are germane, with some children prescribed
fewer medications because of symptom sever-
ity reduction, and other children achieving clin-
ical improvement because of reductions in the
number of medications they were taking. De-
spite this ambiguity in interpretation, it is clear
that the association between clinical improve-
ment and medication reduction is very im-
portant. In structured treatment environments,
prescribing clinicians should be aware of im-
provements in individual patient psychopa-
thology and consider whether these patients
are candidates for a clinical trial of medication
reduction.
Limitations
This study was carried out at a single site, and
this site, in several respects, may not be typical
of all residential treatment. The medication-
reduction data summarized in this report were
obtained within the context of a focused effort
by treating child and adolescent psychiatrists to
implement best practices, based upon published
standard-of-care guidelines (AACAP 1997;
Steiner 1997). Data from a control condition
were not available within the study. In this clin-
ical setting, children could not be randomized
to medication-reduced and medication-not-
reduced groups for ethical reasons and so re-
sults are suggestive, not definitive. Because of
concern about the reliability of the informants,
clinical psychiatric diagnoses were not used in
the analysis. Some children in our sample may
have had medications reduced because of side
effects or poor tolerability. However, we did not
have this data available for analysis in this re-
port. For all of these reasons, the results of this
study may not fully generalize to studies using
different methodologies or other child and ado-
lescent mental health treatment settings.
SUMMARY
Our results suggest the possibility that, within
the setting of a therapeutic and highly struc-
tured residential treatment environment with
a long length of stay, psychiatric medications
can be reduced for the child with severe and
chronic emotional and behavioral problems.
However, not all children may achieve this re-
duction in medication use. A subset of SED
youths, characterized by improvement in psy-
chopathology symptoms within the context of
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residential treatment, nonstimulant medication
treatment, no history of abusive trauma, and a
more intact family structure characterized by
the continued presence of biological or adop-
tive parents in the child’s life, may best achieve
a reduction in medication use.
REFERENCES
American Academy of Child and Adolescent Psy-
chiatry: Practice parameters for the assessment
and treatment of attention-deficit/hyperactivity
disorder. J Am Acad Child Adolesc Psychiatry 36:
85S–121S, 1997.
Connor DF, Ozbayrak KR, Harrison RJ, Melloni
RH, Jr: Prevalence and patterns of psychotropic
and anticonvulsant medication use in children
and adolescents referred to residential treatment.
J Child Adolesc Psychopharmacol 8:27–38, 1998.
Connor DF, Ozbayrak KR, Kusiak KA, Caponi AB,
Melloni RH, Jr: Combined pharmacotherapy in
children and adolescents in a residential treat-
ment center. J Am Acad Child Adolesc Psychiatry
36:248–254, 1997.
Jensen PS, Bhatara VS, Vitiello B, Hoagwood K, Feil
M, Burke LB: Psychoactive medication prescrib-
ing practices for U.S. children: Gaps between re-
search and clinical practice. J Am Acad Child
Adolesc Psychiatry 38:557–565, 1999.
Naglieri JA, LeBuffe PA, Pfeiffer SI: Devereux
Scales of Mental Disorders. San Antonio (Texas),
The Psychological Corporation, 1994.
Olfson M, Marcus SC, Weissman M, Jensen P: Na-
tional trends in the use of psychotropic medi-
cations by children. J Am Acad Child Adolesc
Psychiatry 41:514–521, 2002.
Patel NC, Sanchez RJ, Johnsrud MT, Crismon ML:
Trends in antipsychotic use in a Texas Medicaid
population of children and adolescents: 1996 to
2000. J Child Adolesc Psychopharmacol 12:221–
229, 2002.
Safer DJ, Zito JM, dosReis S: Concomitant psycho-
tropic medication for youths. Am J Psychiatry
160:438–449, 2003.
Steiner H: Practice parameters for the assessment
and treatment of children and adolescents with
conduct disorder. American Academy of Child and
Adolescent Psychiatry. J Am Acad Child Adolesc
Psychiatry 36:122S–139S, 1997.
Zito JM, Safer DJ, dosReis S, Gardner JF, Boles M,
Lynch F: Trends in the prescribing of psychotro-
pic medications to preschoolers. JAMA 283:1025–
1030, 2000.
Zito JM, Safer DJ, dosReis S, Gardner JF, Magder
LS, Soeken K, Boles M, Lynch F, Riddle MA: Psy-
chotropic practice patterns for youth: A 10-year
perspective. Arch Pediatr Adolesc Med 157:17–
25, 2003.
Address reprint requests to:
Daniel F. Connor, M.D.
Department of Psychiatry—7th Floor
Room S7-850
University of Massachusetts Medical School
55 Lake Avenue, North
Worcester, MA 01655
E-mail: daniel.connor@umassmed.edu
310 CONNOR AND MCLAUGHLIN
13961C19.pgs  5/3/05  11:52 AM  Page 310
This article has been cited by:
1. Annette K. Griffith, Gail Smith, Jonathan C. Huefner, Michael H. Epstein, Ronald Thompson, Nirbhay N. Singh, Laurel.K.
Leslie. 2012. Youth at Entry to Residential Treatment: Understanding Psychotropic Medication Use. Children and Youth
Services Review . [CrossRef]
2. D. Lafortune, D. Meilleur, J. Bellavance. 2011. Placement hors du milieu familial et usage des médicaments psychotropes.
Neuropsychiatrie de l'Enfance et de l'Adolescence . [CrossRef]
3. Annette K. Griffith, Jacqueline Huscroft-D’Angelo, Michael H. Epstein, Nirbhay N. Singh, Jonathan C. Huefner, Robert Pick.
2010. Psychotropic Medication Use for Youth in Residential Treatment: A Comparison Between Youth with Monopharmacy
Versus Polypharmacy. Journal of Child and Family Studies 19:6, 795-802. [CrossRef]
4. Julian D. Ford, Lisa A. Fraleigh, David B. Albert, Daniel F. Connor. 2010. Child abuse and autonomic nervous system
hyporesponsivity among psychiatrically impaired children. Child Abuse & Neglect 34:7, 507-515. [CrossRef]
5. Julie Desjardins, Denis Lafortune, Francine Cyr. 2010. La pharmacothérapie dans les centres de rééducation : portrait des
enfants placés qui reçoivent des services médicaux. La psychiatrie de l'enfant 53:1, 285. [CrossRef]
6. Julian D. Ford, Lisa A. Fraleigh, Daniel F. Connor. 2009. Child Abuse and Aggression Among Seriously Emotionally
Disturbed Children. Journal of Clinical Child & Adolescent Psychology 39:1, 25-34. [CrossRef]
7. Michael L. Handwerk , Gail L. Smith , Ronald W. Thompson , Douglas F. Spellman , Daniel L. Daly . 2008. Psychotropic
Medication Utilization at a Group-Home Residential Facility for Children and Adolescents. Journal of Child and Adolescent
Psychopharmacology 18:5, 517-525. [Abstract] [Full Text PDF] [Full Text PDF with Links]
